NEW YORK (GenomeWeb News) - Population Diagnostics and Empire Genomics have signed a co-marketing agreement with the goal of developing molecular diagnostic tests, Population Diagnostics said today.

 

Under the terms of the “multifaceted” deal, EG of Buffalo, NY, will have access to PDI’s core technology platform for discovering copy number polymorphisms. EG will use PDI’s technology to support its internal and collaborative projects, as well as in service and supply relationships with third parties.